EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging Artificial Intelligence to Strengthen Vaccine and Drug Development Capacity in Low-resource African Settings

Courage Chandipwisa, Harrison Banda, Kapembwa Chabala, Tendai Zenda, Agness Shimilimo

Sciences of Pharmacy · 28.04.2026 · 5 (2) · 145-161

DOI: 10.58920/sciphar0501543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sciences of Pharmacy, online erschienen am 28.04.2026. Verfasst von Courage Chandipwisa und 4 weiteren Autor:innen. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Africa’s vaccine and drug research and development capacity remains limited by infrastructural gaps, fragmented data systems, and shortages of skilled personnel, constraining timely therapeutic discovery and clinical translation in low-resource settings. Artificial intelligence (AI) and machine learning offer potential solutions by enabling predictive modelling, accelerating compound screening, improving genomic surveillance, and supporting adaptive clinical trial design. This narrative review synthesizes studies and institutional reports published between 2015 and 2025 from major scientific databases to examine AI applications in vaccine and drug development relevant to African contexts. Thematic analysis identified key patterns related to infrastructure readiness, workforce capacity, and translational implementation, with findings validated through evidence triangulation and consensus review. Results show that AI platforms have supported infectious disease candidate identification, pandemic vaccine development, malaria drug resistance mapping, and predictive analytics for vaccine distribution. While accelerated outcomes were evident during public health emergencies, routine implementation remains constrained by resource availability. Major challenges include inadequate digital infrastructure, fragmented regulatory systems, and limited technical expertise despite ongoing capacity-building initiatives. The review proposes an integrated framework linking infrastructure, skills development, and ethical governance as critical factors for sustainable AI adoption in African biomedical research. Strengthening investment, fostering regional collaboration, and developing context-specific ethical frameworks are essential to ensure equitable access, enhance innovation capacity, and build resilient biomedical research ecosystems across Africa.

Zitieren

APA

Chandipwisa, C., Banda, H., Chabala, K., Zenda, T., & Shimilimo, A. (2026). Leveraging Artificial Intelligence to Strengthen Vaccine and Drug Development Capacity in Low-resource African Settings. Sciences of Pharmacy, 5(2), 145-161. https://doi.org/10.58920/sciphar0501543

Vancouver

Chandipwisa C, Banda H, Chabala K, Zenda T, Shimilimo A. Leveraging Artificial Intelligence to Strengthen Vaccine and Drug Development Capacity in Low-resource African Settings. Sciences of Pharmacy. 2026;5(2):145-161. doi:10.58920/sciphar0501543

BibTeX
@article{Chandipwisa2026,
  author = {Chandipwisa, Courage and Banda, Harrison and Chabala, Kapembwa and Zenda, Tendai and Shimilimo, Agness},
  title = {Leveraging Artificial Intelligence to Strengthen Vaccine and Drug Development Capacity in Low-resource African Settings},
  journal = {Sciences of Pharmacy},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {145--161},
  doi = {10.58920/sciphar0501543}
}
Kostenlos starten →